VuEssence is focused on creating innovative solutions for aiding in the diagnosis and treatment of conditions related to stroke and other neurological injuries*. Despite making strides in recognizing the early signs of stroke and managing conditions that increase risk for the disease, stroke remains a leading cause of death and disability in the US and worldwide.

Recent advances in understanding the human genome and transcriptome have created opportunities for new approaches to diagnosing, managing and treating disease. We are utilizing advanced molecular analysis technologies to develop specialized diagnostic devices that will be able to help in the detection and management of stroke and related conditions.

*Investigational, not available for sale in the United States.

Advanced technologies of the human genome and transcription